Regorafenib in metastatic colorectal cancer: An exploratory biomarker trial.

被引:0
|
作者
Salem, Mohamed E.
Petricoin, Emanuel
Wellstein, Anton
Pierobon, Mariaelena
Wang, Hongkun
Mikhail, Sameh
Hartley, Marion L.
Smaglo, Brandon George
Lou, Emil
Alistar, Angela Tatiana
Dorsch-Vogel, Karen
Pishvaian, Michael J.
He, Aiwu Ruth
Kim, Alexander Y.
Shivapurkar, Narayan
Reddy, Sandeep K.
Marshall, John
机构
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[2] George Mason Univ, Manassas, VA USA
[3] Ohio State Univ, James Canc Hosp, Ctr Comprehens Canc, Solove Res Inst, Columbus, OH 43210 USA
[4] Univ Minnesota, Hopkins, MN USA
[5] Wake Forest Sch Med, Winston Salem, NC USA
[6] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[7] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Med & Oncol, Washington, DC USA
[8] Georgetown Univ, Lombardi Comprehens Canc Ctr, Innovat Ctr Biomed Informat, Washington, DC USA
[9] Medstar Georgetown Univ Hosp, Intervent Radiol, Washington, DC USA
[10] Caris Life Sci, Phoenix, AZ USA
关键词
D O I
10.1200/jco.2016.34.4_suppl.tps773
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS773
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study
    Ramaswamy, Anant
    Ostwal, Vikas
    Pande, Nikhil
    Sharma, Atul
    Patil, Shekar
    Thippeswamy, Ravi
    Ghadyalpatil, Nikhil
    Roy, Rakesh
    Peshwe, Harish
    Poladia, Bhavesh
    Rajamanickam, Deepan
    Rangarajan, Bharat
    Reddy, P. R. Neelesh
    Pandita, Vimal
    Mukherjee, Ashis
    Thoke, Aniket
    Sarkar, Abhijit
    Satish, C. T.
    Shashidara, H.
    Banavali, S. D.
    SOUTH ASIAN JOURNAL OF CANCER, 2019, 8 (01) : 22 - +
  • [2] Exploratory biomarker findings from regorafenib plus toripalimab in patients with refractory metastatic colorectal cancer (REGOTORI study)
    Yao, Y.
    Jin, Y.
    Wang, M.
    Hou, T.
    Chen, Y.
    He, M.
    Li, M.
    Huang, Y.
    Wang, Z.
    Lv, Z.
    Zou, X.
    Zhao, Q.
    Wang, F.
    ANNALS OF ONCOLOGY, 2022, 33 : S310 - S310
  • [3] Regorafenib for metastatic Colorectal Cancer?
    Bossenmayer, Susanne
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (12) : 563 - 563
  • [4] Regorafenib in metastatic colorectal cancer
    Sartore-Bianchi, Andrea
    Zeppellini, Annalisa
    Amatu, Alessio
    Ricotta, Riccardo
    Bencardino, Katia
    Siena, Salvatore
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (03) : 255 - 265
  • [5] Regorafenib for metastatic colorectal cancer
    Andre, Thierry
    Raymond, Eric
    de Gramont, Aimery
    LANCET, 2013, 381 (9877): : 1536 - 1537
  • [6] Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer
    Karasic, Thomas B.
    Brown, Timothy J.
    Schneider, Charles
    Teitelbaum, Ursina R.
    Reiss, Kim A.
    Mitchell, Tara C.
    Massa, Ryan C.
    O'Hara, Mark H.
    DiCicco, Lisa
    Garcia-Marcano, Luis
    Amaravadi, Ravi K.
    O'Dwyer, Peter J.
    ONCOLOGIST, 2022, 27 (09): : 716 - +
  • [7] PHASE 3 CORRECT TRIAL OF REGORAFENIB IN METASTATIC COLORECTAL CANCER (MCRC)
    Sobrero, Alberto
    Grothey, Axel
    Van Cutsem, Eric
    Siena, Salvatore
    Falcone, Alfredo
    Ychou, Marc
    Humblet, Yves
    Bouche, Olivier
    Mineur, Laurent
    Barone, Carlo
    Adenis, Antoine
    Tabernero, Josep
    Yoshino, Takayuki
    Lenz, Heinz Joseph
    Goldberg, Richard
    Sargent, Daniel
    Cihon, Frank
    Jeffers, Michael
    Wagner, Andrea
    Laurent, Dirk
    ANNALS OF ONCOLOGY, 2012, 23 : 15 - 16
  • [8] Regorafenib for metastatic colorectal cancer Reply
    Van Cutsem, Eric
    Grothey, Axel
    LANCET, 2013, 381 (9877): : 1538 - 1539
  • [9] Regorafenib: A Review in Metastatic Colorectal Cancer
    Dhillon, Sohita
    DRUGS, 2018, 78 (11) : 1133 - 1144
  • [10] Regorafenib in the treatment of metastatic colorectal cancer
    de la Fouchardiere, Christelle
    FUTURE ONCOLOGY, 2018, 14 (22) : 2239 - 2246